Fenwick & West Represents Omada Health in $48 Million Series C Financing

September 16, 2015

Fenwick & West represented Omada Health, Inc., a digital behavioral medicine company, in its $48 million Series C financing. The round was led by Norwest Venture Partners. Its strategic investors include two Omada customers and health care leaders – Humana Inc. (NYSE: HUM) and Providence Health & Services, as well as prior investors US Venture Partners, Rock Health, and Andreessen Horowitz, and new investors GE Ventures and dRx Capital.

The new capital will be used to meet market demand, expand the company’s rigorous clinical research and publishing schedule, and drive continuous improvement and enhancement of Prevent, the company’s flagship program. 

The Fenwick transaction team was led by partners Michael Esquivel and Stefano Quintini and corporate associates Daniel Parames and Ryan McRobert​.